Premium Industrial News
Key Players in China's CDMO Pharma-Bio Market Push ForwardKey Players in China's CDMO Pharma-Bio Market Push Forward
Industry Segment: Pharmaceutical & Biotech | Word Count: 294 Words
BEIJING--June 11, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--Key players in the Chinese contract development and manufacturing organization (CDMO) market such as Wuxi AppTec & Wuxi Biologics, Asymchem Laboratories (Tianjin) Co., Ltd., Porton Pharma Solutions Ltd., Apeloa Pharmaceutical Co., Ltd and Zhejiang Jiuzhou Pharmaceutical Co. Ltd, among others, have employed various strategies to expand their product and application offerings and global footprint, and augment their market share.
This Premium Article can be purchased individually or as part of a subscription
Subscribe Now!(All Fields Required)
Related Articles
Articles related to the Pharmaceutical & Biotech industry
- China's Pharmaceutical Companies Turn Attention to Monoclonal Antibodies
- China Authorizes Five Companies to Make COVID-19 Vaccines
- China's Pharma Companies Face Fiscal Challenges for R&D Projects
- Real Estate Developers Pour $34 Billion into Global Life Science Building D...
- China's Pharma Market Could See New Growth Wave as India's Plants Close
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
